Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissection

Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissection - Efficacy and safety of Hybrid-ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022545

Enrollment

Registered

2016-06-01

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal adenoma/intramucosal cancer

Interventions

Patients with 20-30mm colorectal adenoma/intramucosal cancer were considered eligible. Hybrid ESD was performed using newly-developed device which enable scircumferential incision and submucosal di

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with 20-30mm colorectal adenoma/intramucosal cancer were consequentially enrolled in the present study.

Exclusion criteria

Exclusion criteria: We exclude patients with colorectal adenoma/intramucosalcancer larger than 30mm. Patients whose lesions were found to be outside the guideline or expanded criteria for ESD by the endoscopic characteristics and histological findings of biopsy specimens. Patients in disagreement with informed consent

Design outcomes

Primary

Measure	Time frame
Complication rate assessed after endoscopic treatment	—

Secondary

Measure	Time frame
Procedure time, The rate of adverse events (perforation, delayed bleeding) These autcomes were assessed one Month after the treatment	—

Countries

Japan

Contacts

Public ContactEiji Sakai

NTT Medical Center Tokyo Department of Gastroenterology

eiji525@yokohama-cu.ac.jp+81-3-3448-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026